Fig. 1From: Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancerParameter definitions. a Progression-free survival during the first-line chemotherapy (1st PFS) curve for all the 136 patients included in this study. b Correlation analysis between NLR and PLR. c ROC curve for NLR and PLR to determine the cut-off values at the median 1st PFS. d Schematic figures of cNPLDS and risk classificationsBack to article page